NCT01113216
Genetic Modifiers of Cystic Fibrosis Related Diabetes
Enrolling by Invitation
Not specifiedAges 3–99ObservationalJohns Hopkins UniversityInvestigator-initiated
~1,500 participants
Updated 2026-04-13 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Identification of Genes or other factors that influence the development of CFRD
Measured over 5 years
Conditions
Where it's being run
3 sites across 3 statesIllinois1
Maryland1
Minnesota1
Study leadership
- Scott M Blackman, MD, PhD · PRINCIPAL_INVESTIGATOR · Johns Hopkins University
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Any person with Cystic Fibrosis and his/her parents.
Exclusion
None
What this trial measures
- Identification of Genes or other factors that influence the development of CFRD5 years